|
|
||||||||


Departments of
* Microbiology and Immunology and
Biomedical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY 14853; and
Department of Pathology, Harvard University Medical School, Boston, MA 02115
The role of the third component of complement (C3) during
schistosome infection was investigated using mice deficient in C3.
While no effect was observed 8 wk after infection on worm development
or liver pathology, Ag-specific Th2-associated cytokine production
(IL-13, IL-5, IL-6, and IL-10) was significantly reduced, and IFN-
production was enhanced in the absence of C3. IgG1 and IgE, but not
IgG2a or IgM, Ab responses were also significantly impaired in infected
C3-/- mice, suggesting that C3 may play a role in
IL-4-mediated Th2 response enhancement during schistosome infection.
Furthermore, C3-deficient mice could not effectively clear adult worms
after praziquantel (PZQ) treatment and suffered increased morbidity due
to the overproduction of proinflammatory mediators following drug
administration. However, the ischemic liver damage that normally
accompanies PZQ administration in infected wild-type mice was
substantially reduced in treated C3-deficient mice, probably due to the
absence of dead or dying worms in the livers of these animals. Together
these results indicate that C3 enhances Th2 responses during
schistosome infection, potentiates PZQ-mediated parasite clearance, and
reduces chemotherapy-induced proinflammatory mediator
production.
This article has been cited by other articles:
![]() |
L. A. Kerepesi, J. A. Hess, T. J. Nolan, G. A. Schad, and D. Abraham Complement Component C3 Is Required for Protective Innate and Adaptive Immunity to Larval Strongyloides stercoralis in Mice J. Immunol., April 1, 2006; 176(7): 4315 - 4322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Stavitsky Regulation of Granulomatous Inflammation in Experimental Models of Schistosomiasis Infect. Immun., January 1, 2004; 72(1): 1 - 12. [Full Text] [PDF] |
||||
![]() |
C. Taube, Y.-H. Rha, K. Takeda, J.-W. Park, A. Joetham, A. Balhorn, A. Dakhama, P. C. Giclas, V. M. Holers, and E. W. Gelfand Inhibition of Complement Activation Decreases Airway Inflammation and Hyperresponsiveness Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1333 - 1341. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |